Post by rojonirabeya1 on Mar 10, 2024 4:27:06 GMT
The American biotechnology company is considering setting the price between 110 dollars (about 102 euros, at the current exchange rate) and 130 dollars ( 121 euros ) for each dose in the United States, which would mean an increase of more than 400% or 500%. exact, respectively, compared to the 26 dollars (24 euros) per dose of the last contract, signed in July 2022, reports The Wall Street Journal ( WSJ ). "I think this type of price is consistent with the value" provided by the vaccine, stated Stéphane Bancel, CEO of Moderna, this Monday the 9th in an interview with the media. The adjustment, if confirmed, would take place in a context in which, on the one hand, the acquisition of coronavirus vaccines will move from government contracting to commercial distribution in the United States. Young people, women, immigrants and low incomes, the most affected by the pandemic: this is how the COVID-19 crisis has hit Spain.
The federal government, which until now has purchased the doses and made them available to the population for free - as is the case in Spain - has announced that companies will have to switch to standard commercial distribution when the supply secured by Asia Phone Number List the government contracts. On the other hand, the increase would match that proposed by one of its main competitors, Pfizer , which in October advanced its plans to raise the price to the range of 110 or 130 dollars. The pharmaceutical company, also American, then received harsh criticism for the price increase, described as "pure and deadly greed" and an exercise in "unseemly speculation" by two Democratic senators, Elizabeth Warren and Peter Welch, reports Ars Technica.
We urge you to desist from your proposed price increase and ensure that COVID-19 vaccines are reasonably priced and accessible to people throughout the United States," they demand in a letter sent last month to Albert Bourla, president from Pfizer. How much money would you have earned if you had invested 1,000 euros 3 years ago in the pharmaceutical companies that today lead the coronavirus vaccine race? The COVID-19 vaccine has been rising in price both in the US (the original dose cost between 15 and 16 dollars) and in the European Union (15.50 euros before August 2021) and has been an important source of income for the companies that sell them. In its first year on the market since its emergency authorization, sales exceeded 53 billion euros . Pfizer and Moderna, specifically, earned 9 out of every 10 euros invoiced in 2021 from the sale of these injections.